Key facts
- It has raised $200K; the latest was Later Stage VC in Mar 2026.
- Notable investors include SOSV, IndieBio, HiCenter, Israeli National Center of Blue Economy, Twynam Funds Management.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for DisperseBio
- ·The full record, as it builds
Funding rounds
No funding rounds for DisperseBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DisperseBio
Developer of resistant materials designed to combat microbial contamination caused by biofilms in critical sectors and healthcare systems. The company offers an eco-friendly and cost-effective system for combating biofilm, enabling clients in sectors such as marine coatings, desalination, water treatment, and medicine to reduce reliance on toxic antimicrobial chemicals.
- Sector
- Materials and Resources
- HQ
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 2
- Website
- dispersebio.com/
- Ownership
- Privately Held (backing)
DisperseBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DisperseBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DisperseBio in its N-PORT filings yet. We sweep new filings monthly.